Famotidine

Product NDC: 53002-6670
11-digit product format: 530026670
Labeler code: 53002
Product ID: 53002-6670_108790ff-607f-4326-9954-a76ade0f85e7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Famotidine
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: RPK Pharmaceuticals, Inc.
Application: ANDA206530
Marketing category: ANDA
Marketing start: 2015-12-22
Marketing end: 0000-00-00
Substance: FAMOTIDINE
Active strength: 40 mg/1
Pharmacologic classes: Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	53002-6670		I	Inactivated by FDA	2026-08-03
excluded package	package	53002-6670	53002-6670-1	I	Inactivated by FDA	2026-08-03
excluded package	package	53002-6670	53002-6670-2	I	Inactivated by FDA	2026-08-03
excluded package	package	53002-6670	53002-6670-3	I	Inactivated by FDA	2026-08-03
excluded package	package	53002-6670	53002-6670-6	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 55 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-6670-6	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-6670-2	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-6670-1	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-6670-3	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-6670-6	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-6670-2	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-6670-1	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-6670-3	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-6670-6	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-6670-2	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-6670-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-6670-3	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-6670-6	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-6670-2	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-6670-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-6670-3	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-6670-6	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-6670-2	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-6670-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-6670-3	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-6670-6	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-6670-2	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-6670-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-6670-3	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-6670-6	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-6670-2	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-6670-1	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-6670-3	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-6670-6	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-6670-2	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-6670-1	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-6670-3	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-6670-6	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-6670-2	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-6670-1	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-6670-3	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-6670-3	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-6670-6	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-6670-2	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-6670-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-6670-3	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-6670-6	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-6670-2	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-6670-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A206530-001	FAMOTIDINE	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22
A206530-002	FAMOTIDINE	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A206530-001	AB
A206530-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB		2015-12-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206530-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206530-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206530-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206530-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206530-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206530-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206530-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206530-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206530-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206530-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206530-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206530-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206530-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206530-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206530-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206530-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206530-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206530-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206530-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206530-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206530-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206530-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206530-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206530-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206530-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206530-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206530-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206530-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206530-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206530-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206530-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206530-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206530-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206530-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206530-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206530-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206530-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206530-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A206530-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A206530-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae	Product name	7	20260317
1e73f975-1ce7-705e-2bcf-788b1b5e24ba	Product name	5	20251124
cf645750-2e70-f6e1-c05a-a52847def5dd	Product name	9	20250312
4fdc761c-585e-054b-8ebe-86130a26e4c1	Product name	2	20221205
fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
53002-6670-1	2025-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-2	2025-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-3	2025-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-6	2025-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-1	2023-06-08	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-2	2023-06-08	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-3	2023-06-08	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-6	2023-06-08	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-1	2023-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-2	2023-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-3	2023-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-6	2023-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-1	2020-12-17	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-2	2020-12-17	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-3	2020-12-17	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-6	2020-12-17	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-1	2020-01-31	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-2	2020-01-31	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-3	2020-01-31	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
53002-6670-6	2020-01-31	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
53002-6670-1	Famotidine	10 in 1 BOTTLE	TABLET, FILM COATED	10	5
53002-6670-2	Famotidine	20 in 1 BOTTLE	TABLET, FILM COATED	20	5
53002-6670-3	Famotidine	30 in 1 BOTTLE	TABLET, FILM COATED	30	5
53002-6670-6	Famotidine	60 in 1 BOTTLE	TABLET, FILM COATED	60	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53002-6670	FAMOTIDINE TABLET, FILM COATED [RPK PHARMACEUTICALS, INC.]	5	Legacy NDC, 4 package rows	20230609_ba35f425-9321-4fd8-91d4-053a1edb3a05.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Famotidine	FAMOTIDINE	Unit Dose Solutions, Inc.	54d93bf1-8f9a-981b-e063-6394a90a0fde	2026-06-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	Bryant Ranch Prepack	11ce2a78-76ce-44df-afe3-57493498e596	2025-04-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	Aurobindo Pharma Limited	b0798337-1a73-415e-8416-613984ce5c65	2025-03-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	American Health Packaging	3a583080-6771-4246-a221-2491e9e5d8af	2024-09-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	Proficient Rx LP	4adb4864-04ac-4cb1-96c2-6196a30ac640	2024-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	A-S Medication Solutions	d8cfa644-7cad-41b9-82a0-242a783fcbc8	2023-12-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	Proficient Rx LP	f32d0929-de22-4bec-9e24-bb549cf2679f	2022-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	BluePoint Laboratories	8c7ca3cc-ff90-42a7-9218-554cf15348a3	2021-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5QZO15J2Z8	FAMOTIDINE	76824-35-6	FAMOTIDINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
284245	famotidine 40 MG Oral Tablet	PSN	ba35f425-9321-4fd8-91d4-053a1edb3a05	5
284245	famotidine 40 MG Oral Tablet	SCD	ba35f425-9321-4fd8-91d4-053a1edb3a05	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
53002-6670-1	53002667001	10 TABLET, FILM COATED in 1 BOTTLE (53002-6670-1)	2018-10-01	0000-00-00	No	No	Current
53002-6670-2	53002667002	20 TABLET, FILM COATED in 1 BOTTLE (53002-6670-2)	2018-10-01	0000-00-00	No	No	Current
53002-6670-3	53002667003	30 TABLET, FILM COATED in 1 BOTTLE (53002-6670-3)	2018-10-01	0000-00-00	No	No	Current
53002-6670-6	53002667006	60 TABLET, FILM COATED in 1 BOTTLE (53002-6670-6)	2018-10-01	0000-00-00	No	No	Current